Jürgen Reiher has spent more than 20 years in the life sciences industry providing clients with implementable commercial, pricing, reimbursement and market access strategies and tactics. He helps clients develop their market access strategies and then translate them into commercial strategies. Jürgen’s broad experience and deep understanding of the payer, thought leader, policy, and regulatory environment in markets throughout the EU, allow him to work at a strategic and tactical level, helping clients from dossier preparation through submission. Jürgen has advised large and small biotech, pharma and generic companies seeking to expand or defend existing markets and geographies. His indication experience includes oncology, hematology, vaccines, respiratory, rheumatology, neurology, endocrinology, women’s health, as well as significant orphan drug experience. Prior to working in industry, he spent five years conducting bench research in neuroendocrinology.